Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.682
-0.009 (-1.30%)
Apr 29, 2026, 9:38 AM EDT - Market open
Tenaya Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -90.6 | -111.13 | -124.08 | -123.67 | -72.72 | |
| Depreciation & Amortization | 8.44 | 8.47 | 8.69 | 6.47 | 2.96 | |
| Loss (Gain) From Sale of Investments | 0.41 | -0.18 | 0.32 | -0.31 | 0.13 | |
| Stock-Based Compensation | 13.05 | 16.5 | 15.31 | 11.47 | 2.95 | |
| Other Operating Activities | 2.9 | 3.77 | 3.35 | 2.46 | 1.13 | |
| Change in Accounts Payable | -1.43 | -0.58 | -3.28 | 1.66 | 8.6 | |
| Change in Other Net Operating Assets | -1.03 | -7.35 | -2.37 | -2.51 | -3.86 | |
| Operating Cash Flow | -68.26 | -90.5 | -102.07 | -104.42 | -60.81 | |
| Capital Expenditures | -0.62 | -1.03 | -1.24 | -20.63 | -25.12 | |
| Investment in Securities | 56.7 | 2.14 | 49.98 | 104.27 | -213.44 | |
| Other Investing Activities | - | 0.02 | -0.03 | 0.01 | - | |
| Investing Cash Flow | 56.08 | 1.13 | 48.72 | 83.65 | -238.56 | |
| Issuance of Common Stock | 108.41 | 47.75 | 4.55 | 77.77 | 189 | |
| Repurchase of Common Stock | - | - | - | - | -0.01 | |
| Other Financing Activities | - | - | -0.5 | - | - | |
| Financing Cash Flow | 108.41 | 47.75 | 4.05 | 77.77 | 208.97 | |
| Net Cash Flow | 96.22 | -41.62 | -49.31 | 57 | -90.41 | |
| Free Cash Flow | -68.88 | -91.53 | -103.31 | -125.05 | -85.93 | |
| Free Cash Flow Per Share | -0.45 | -1.08 | -1.40 | -2.79 | -4.85 | |
| Levered Free Cash Flow | -37.36 | -52.73 | -60.78 | -83.92 | -52.6 | |
| Unlevered Free Cash Flow | -37.36 | -52.73 | -60.78 | -83.92 | -52.6 | |
| Change in Working Capital | -2.46 | -7.93 | -5.65 | -0.85 | 4.74 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.